PHIO icon

Phio Pharmaceuticals
PHIO

Overview Fund Activity

26 hedge funds and large institutions have $3.51M invested in Phio Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
8
Increased
5
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$368K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$167K
3
TAM
3
Tocqueville Asset Management
New York
$100K
4
TCM
4
Tang Capital Management
California
$100K
5
SIM
5
Spark Investment Management
New York
$110K

Top Sellers

1
SFM
1
Sphera Funds Management
Israel
$0
2
VKH
2
Virtu KCG Holdings
New York
$0
3
Jane Street
3
Jane Street
New York
$56K
4
CS
4
Credit Suisse
Switzerland
$163K
5
Barclays
5
Barclays
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Ameriprise
26
Ameriprise
Minnesota
$0 1 -11 -92%
TDC
27
Thompson Davis & Co
Virginia
– – – –
PRCM
28
Pine River Capital Management
Minnesota
$0 145,000 – –
Wells Fargo
29
Wells Fargo
California
$0 5 – –
Citigroup
30
Citigroup
New York
$0 7 – –
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$0 61 – –
NFG
32
Next Financial Group
Texas
$0 66 +66 New
1
2